ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 85 filers reported holding ATRECA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,757 | -73.4% | 110,179 | 0.0% | 0.00% | – |
| Q2 2023 | $107,975 | -57.0% | 110,179 | -50.0% | 0.00% | – |
| Q1 2023 | $251,208 | +184.8% | 220,358 | +100.0% | 0.00% | – |
| Q4 2022 | $88,209 | -49.0% | 110,179 | -0.1% | 0.00% | – |
| Q3 2022 | $173,000 | -12.6% | 110,326 | -0.2% | 0.00% | – |
| Q2 2022 | $198,000 | -45.2% | 110,557 | -3.0% | 0.00% | – |
| Q1 2022 | $361,000 | +17950.0% | 113,962 | +22692.4% | 0.00% | – |
| Q4 2021 | $2,000 | -99.7% | 500 | -99.0% | 0.00% | – |
| Q1 2021 | $760,000 | -70.8% | 49,588 | -69.2% | 0.00% | – |
| Q4 2020 | $2,600,000 | +15.6% | 160,988 | 0.0% | 0.00% | – |
| Q3 2020 | $2,249,000 | +169.0% | 160,988 | +309.6% | 0.00% | – |
| Q2 2020 | $836,000 | +28.6% | 39,300 | 0.0% | 0.00% | – |
| Q1 2020 | $650,000 | -64.3% | 39,300 | -66.6% | 0.00% | – |
| Q4 2019 | $1,821,000 | +26.4% | 117,700 | 0.0% | 0.00% | – |
| Q3 2019 | $1,441,000 | -35.0% | 117,700 | 0.0% | 0.00% | – |
| Q2 2019 | $2,217,000 | – | 117,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,396,644 | $23,000,000 | 5.25% |
| EcoR1 Capital, LLC | 2,426,685 | $39,191,000 | 2.11% |
| Boxer Capital, LLC | 2,202,333 | $35,568,000 | 1.14% |
| Aisling Capital Management LP | 387,653 | $6,261,000 | 1.08% |
| CM Management, LLC | 60,000 | $969,000 | 0.90% |
| Samsara BioCapital, LLC | 474,943 | $7,670,000 | 0.77% |
| Parkman Healthcare Partners LLC | 126,258 | $2,039,000 | 0.52% |
| Redmile Group, LLC | 2,476,068 | $39,988,000 | 0.48% |
| Sio Capital Management, LLC | 128,455 | $2,075,000 | 0.42% |
| HighVista Strategies LLC | 30,824 | $498,000 | 0.32% |